
1001 - 5000 employees
Founded 2002
🧬 Biotechnology
💊 Pharmaceuticals
🏥 Healthcare
💰 $661.3M Post-IPO Debt on 2025-09
Biotechnology • Pharmaceuticals • Healthcare
Alnylam Pharmaceuticals is a biopharmaceutical company that pioneers RNA interference (RNAi) therapeutics to silence disease-causing genes. The company develops RNAi-based medicines across rare and prevalent diseases, with a pipeline, approved products, and manufacturing capabilities focused on delivering transformational treatments (e. g. , for amyloidosis, acute hepatic porphyria, and primary hyperoxaluria). Alnylam emphasizes scientific innovation, patient-centered development, and corporate responsibility.
📡 We watch Alnylam Pharmaceuticals's careers page
Every 2 hours
how often we check
7
roles posted in the last 30 days
Selected: 🇺🇸 United States – Remote USA.
Selected: 🆕 Date Added.
🔥 5 minutes ago
Business Account Executive promoting Alnylam Pharmaceuticals’ AMVUTTRA RNAi therapy for TTR amyloidosis. Building provider relationships, driving product adoption, and achieving territory sales targets across South Alabama.
🏈 Alabama – Remote
💵 $144.5k - $195.5k / year
💰 $661.3M Post-IPO Debt on 2025-09
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🔥 5 minutes ago
Business Account Executive promoting Alnylam’s rare-disease RNAi therapies, GIVLAARI® and OXLUMO®. Driving physician engagement, patient identification, market development, and territory sales across Northern California and Southern Oregon.
🏄 California, Oregon – Remote
💵 $160.7k - $217.3k / year
💰 $661.3M Post-IPO Debt on 2025-09
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🔥 5 minutes ago
Business Account Executive commercializing Alnylam’s rare-disease therapies, GIVLAARI® and OXLUMO®. Driving physician and patient identification, market development, and territory sales across Upstate New York and Central Pennsylvania.
🗽 New York, Pennsylvania – Remote
💵 $160.7k - $217.3k / year
💰 $661.3M Post-IPO Debt on 2025-09
⏰ Full Time
🟡 Mid-level
🟠 Senior
🧑💼 Account Executive
👻 Ghost score 0%
🔥 5 minutes ago
Associate Director advancing KOL engagement, TLL effectiveness, and field education at Alnylam Pharmaceuticals. Translating stakeholder insights into compliant commercial strategy and execution.
🇺🇸 United States – Remote
💵 $161.5k - $218.5k / year
💰 $661.3M Post-IPO Debt on 2025-09
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 0%
🔥 5 minutes ago
Associate Director optimizing reimbursement access for Alnylam’s RNAi therapeutics across North Dakota, South Dakota, Minnesota, Iowa, and Wisconsin. Supporting providers, payers, and patient treatment pathways.
🌾 Iowa, North Dakota, +3 more states – Remote
💵 $174.3k - $235.7k / year
💰 $661.3M Post-IPO Debt on 2025-09
⏰ Full Time
🟠 Senior
👔 Director
👻 Ghost score 0%